Sanofi Historical Balance Sheet

SNY Stock

USD 48.28 0.30 0.63%

Trend analysis of Sanofi ADR balance sheet accounts such as Total Stockholder Equity of 50.5 B, Property Plant And Equipment Net of 8.5 B, Net Debt of 7.6 B or Accounts Payable of 3.7 B provides information on Sanofi ADR's total assets, liabilities, and equity, which is the actual value of Sanofi ADR to its prevalent stockholders. By breaking down trends over time using Sanofi ADR balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Sanofi ADR latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Sanofi ADR is a good buy for the upcoming year.

Sanofi ADR Inventory

5.61 Billion

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanofi ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.

About Sanofi Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Sanofi ADR at a specified time, usually calculated after every quarter, six months, or one year. Sanofi ADR Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Sanofi ADR and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Sanofi currently owns. An asset can also be divided into two categories, current and non-current.

Sanofi ADR Balance Sheet Chart

At this time, Sanofi ADR's Other Current Liabilities is fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 13.7 B in 2024, whereas Total Assets are likely to drop slightly above 88.7 B in 2024.

Total Assets Short Long Term Debt Total Other Current Liab

Add Fundamental

Total Assets

Total assets refers to the total amount of Sanofi ADR assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Sanofi ADR books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Most accounts from Sanofi ADR's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Sanofi ADR current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanofi ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.At this time, Sanofi ADR's Other Current Liabilities is fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 13.7 B in 2024, whereas Total Assets are likely to drop slightly above 88.7 B in 2024.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	22.4B	21.2B	18.4B	13.7B
Total Assets	120.2B	126.7B	126.5B	88.7B

Short Long Term Debt Total Total Assets

Sanofi ADR balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets
Total Assets		0.88	0.55	0.93	0.99	0.97	0.66	0.84	0.78	0.99	0.13	0.69	0.85	1.0	0.87	0.25	-0.61	0.91	0.97	0.38	-0.17	0.98	0.42	0.9	0.6	0.79
Short Long Term Debt Total	0.88		0.47	0.85	0.81	0.8	0.86	0.75	0.75	0.85	-0.06	0.71	0.7	0.88	0.6	0.09	-0.37	0.89	0.88	0.31	-0.4	0.94	0.2	0.83	0.6	0.69
Other Current Liab	0.55	0.47		0.71	0.56	0.43	0.24	0.7	0.57	0.5	0.67	0.61	0.16	0.54	0.4	-0.11	0.0	0.31	0.62	0.53	0.1	0.51	0.76	0.61	0.24	0.4
Total Current Liabilities	0.93	0.85	0.71		0.92	0.85	0.6	0.94	0.81	0.89	0.23	0.77	0.67	0.92	0.7	-0.02	-0.35	0.74	0.96	0.52	-0.16	0.9	0.46	0.92	0.57	0.64
Total Stockholder Equity	0.99	0.81	0.56	0.92		0.97	0.56	0.84	0.78	0.98	0.17	0.69	0.84	0.99	0.88	0.27	-0.6	0.86	0.97	0.38	-0.08	0.95	0.45	0.9	0.58	0.78
Property Plant And Equipment Net	0.97	0.8	0.43	0.85	0.97		0.61	0.75	0.71	0.97	0.08	0.61	0.88	0.97	0.91	0.3	-0.66	0.9	0.92	0.32	-0.07	0.94	0.38	0.85	0.63	0.8
Net Debt	0.66	0.86	0.24	0.6	0.56	0.61		0.56	0.31	0.7	-0.03	0.26	0.6	0.66	0.47	-0.05	-0.32	0.8	0.63	0.06	-0.43	0.77	0.17	0.47	0.52	0.7
Accounts Payable	0.84	0.75	0.7	0.94	0.84	0.75	0.56		0.67	0.82	0.3	0.64	0.57	0.84	0.59	-0.15	-0.26	0.62	0.91	0.38	-0.22	0.8	0.49	0.77	0.4	0.59
Cash	0.78	0.75	0.57	0.81	0.78	0.71	0.31	0.67		0.69	-0.07	0.98	0.54	0.78	0.52	0.24	-0.28	0.63	0.81	0.49	-0.2	0.75	0.15	0.93	0.44	0.39
Non Current Assets Total	0.99	0.85	0.5	0.89	0.98	0.97	0.7	0.82	0.69		0.15	0.6	0.87	0.99	0.88	0.24	-0.63	0.92	0.95	0.28	-0.15	0.97	0.44	0.83	0.6	0.85
Non Currrent Assets Other	0.13	-0.06	0.67	0.23	0.17	0.08	-0.03	0.3	-0.07	0.15		-0.08	-0.06	0.12	0.33	-0.33	-0.12	-0.03	0.18	0.1	0.21	0.08	0.95	0.05	-0.05	0.15
Cash And Short Term Investments	0.69	0.71	0.61	0.77	0.69	0.61	0.26	0.64	0.98	0.6	-0.08		0.41	0.69	0.39	0.18	-0.11	0.52	0.75	0.49	-0.16	0.67	0.12	0.88	0.41	0.32
Net Receivables	0.85	0.7	0.16	0.67	0.84	0.88	0.6	0.57	0.54	0.87	-0.06	0.41		0.85	0.84	0.38	-0.82	0.88	0.73	0.16	-0.24	0.85	0.23	0.7	0.63	0.74
Good Will	1.0	0.88	0.54	0.92	0.99	0.97	0.66	0.84	0.78	0.99	0.12	0.69	0.85		0.86	0.25	-0.6	0.91	0.97	0.36	-0.19	0.98	0.41	0.9	0.58	0.79
Common Stock Total Equity	0.87	0.6	0.4	0.7	0.88	0.91	0.47	0.59	0.52	0.88	0.33	0.39	0.84	0.86		0.33	-0.85	0.83	0.78	0.27	-0.02	0.83	0.59	0.71	0.48	0.72
Common Stock Shares Outstanding	0.25	0.09	-0.11	-0.02	0.27	0.3	-0.05	-0.15	0.24	0.24	-0.33	0.18	0.38	0.25	0.33		-0.46	0.34	0.08	0.14	0.12	0.21	-0.16	0.23	0.11	0.33
Short Term Investments	-0.61	-0.37	0.0	-0.35	-0.6	-0.66	-0.32	-0.26	-0.28	-0.63	-0.12	-0.11	-0.82	-0.6	-0.85	-0.46		-0.69	-0.45	-0.07	0.24	-0.59	-0.34	-0.46	-0.29	-0.46
Non Current Liabilities Total	0.91	0.89	0.31	0.74	0.86	0.9	0.8	0.62	0.63	0.92	-0.03	0.52	0.88	0.91	0.83	0.34	-0.69		0.83	0.22	-0.32	0.96	0.27	0.77	0.55	0.8
Inventory	0.97	0.88	0.62	0.96	0.97	0.92	0.63	0.91	0.81	0.95	0.18	0.75	0.73	0.97	0.78	0.08	-0.45	0.83		0.38	-0.16	0.95	0.43	0.9	0.54	0.72
Other Current Assets	0.38	0.31	0.53	0.52	0.38	0.32	0.06	0.38	0.49	0.28	0.1	0.49	0.16	0.36	0.27	0.14	-0.07	0.22	0.38		0.05	0.37	0.19	0.64	0.1	0.05
Other Stockholder Equity	-0.17	-0.4	0.1	-0.16	-0.08	-0.07	-0.43	-0.22	-0.2	-0.15	0.21	-0.16	-0.24	-0.19	-0.02	0.12	0.24	-0.32	-0.16	0.05		-0.28	0.16	-0.21	0.12	0.06
Total Liab	0.98	0.94	0.51	0.9	0.95	0.94	0.77	0.8	0.75	0.97	0.08	0.67	0.85	0.98	0.83	0.21	-0.59	0.96	0.95	0.37	-0.28		0.37	0.89	0.6	0.79
Property Plant And Equipment Gross	0.42	0.2	0.76	0.46	0.45	0.38	0.17	0.49	0.15	0.44	0.95	0.12	0.23	0.41	0.59	-0.16	-0.34	0.27	0.43	0.19	0.16	0.37		0.31	0.17	0.4
Total Current Assets	0.9	0.83	0.61	0.92	0.9	0.85	0.47	0.77	0.93	0.83	0.05	0.88	0.7	0.9	0.71	0.23	-0.46	0.77	0.9	0.64	-0.21	0.89	0.31		0.51	0.52
Short Term Debt	0.6	0.6	0.24	0.57	0.58	0.63	0.52	0.4	0.44	0.6	-0.05	0.41	0.63	0.58	0.48	0.11	-0.29	0.55	0.54	0.1	0.12	0.6	0.17	0.51		0.63
Intangible Assets	0.79	0.69	0.4	0.64	0.78	0.8	0.7	0.59	0.39	0.85	0.15	0.32	0.74	0.79	0.72	0.33	-0.46	0.8	0.72	0.05	0.06	0.79	0.4	0.52	0.63

Click cells to compare fundamentals

Sanofi ADR Account Relationship Matchups

Sanofi ADR balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	112.6B	114.4B	120.2B	126.7B	126.5B	88.7B
Short Long Term Debt Total	26.0B	23.7B	22.4B	21.2B	18.4B	13.7B
Other Current Liab	6.5B	11.3B	10.9B	11.7B	13.4B	14.0B
Total Current Liabilities	20.4B	19.3B	21.3B	24.0B	24.2B	14.4B
Total Stockholder Equity	59.1B	63.1B	68.7B	74.8B	74.0B	50.5B
Property Plant And Equipment Net	11.0B	10.6B	12.0B	11.7B	11.8B	8.5B
Net Debt	16.5B	9.8B	12.3B	8.5B	9.7B	7.6B
Accounts Payable	5.3B	4.0B	6.2B	6.8B	7.3B	3.7B
Cash	9.4B	13.9B	10.1B	12.7B	8.7B	6.2B
Non Current Assets Total	83.7B	80.6B	89.6B	92.6B	95.8B	66.5B
Non Currrent Assets Other	992M	1.1B	1.1B	1.2B	13.1B	13.7B
Cash And Short Term Investments	9.9B	14.8B	11.2B	13.4B	8.7B	7.1B
Net Receivables	10.1B	7.5B	7.6B	10.7B	8.4B	7.4B
Good Will	44.5B	44.4B	48.1B	49.9B	49.4B	33.9B
Common Stock Shares Outstanding	1.3B	2.5B	2.5B	2.5B	1.3B	2.5B
Short Term Investments	426M	900M	1.1B	664M	270M	256.5M
Liabilities And Stockholders Equity	112.6B	114.4B	120.2B	126.7B	126.5B	88.7B
Non Current Liabilities Total	33.0B	31.9B	29.9B	27.6B	27.9B	23.6B
Inventory	8.0B	8.4B	8.7B	9.0B	9.7B	5.6B
Other Current Assets	1.0B	4.0B	4.3B	4.0B	3.9B	2.2B
Other Stockholder Equity	(47.8B)	(343M)	(407M)	(581M)	(871M)	(914.6M)
Total Liab	53.4B	51.2B	51.2B	51.6B	52.1B	38.0B
Property Plant And Equipment Gross	11.0B	10.6B	12.0B	11.7B	27.4B	28.8B
Total Current Assets	28.9B	33.8B	30.7B	34.1B	30.7B	22.2B
Accumulated Other Comprehensive Income	52.5B	56.8B	62.2B	68.2B	4.9B	4.6B
Short Term Debt	4.8B	3.0B	3.5B	4.5B	2.3B	2.9B
Intangible Assets	16.5B	18.3B	21.4B	21.6B	18.3B	17.9B
Other Liab	12.1B	11.4B	11.0B	10.8B	12.5B	11.9B
Current Deferred Revenue	3.8B	252M	319M	264M	597M	567.2M
Retained Earnings	51.8B	60.1B	63.0B	66.7B	67.5B	64.1B
Other Assets	8.8B	11.4B	13.5B	12.9B	14.8B	9.8B
Long Term Debt	20.1B	19.7B	17.1B	14.9B	14.3B	12.7B
Property Plant Equipment	11.0B	10.6B	12.0B	11.7B	13.4B	10.5B
Deferred Long Term Liab	2.3B	6.1B	7.7B	6.2B	7.2B	4.0B
Long Term Investments	5.3B	7.1B	8.0B	9.2B	2.7B	2.5B
Short Long Term Debt	4.6B	2.8B	3.2B	4.2B	2.0B	3.2B
Net Tangible Assets	177M	6.3B	6.9B	9.5B	8.5B	4.6B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Sanofi Stock Analysis

When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sanofi Historical Balance Sheet

Sanofi ADR Inventory

5.61 Billion

About Sanofi Balance Sheet Analysis

Sanofi ADR Balance Sheet Chart

Total Assets

Sanofi ADR balance sheet Correlations

Sanofi ADR Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Sanofi ADR balance sheet Accounts

Also Currently Popular

Additional Tools for Sanofi Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Good Will	+ 1.0	Total Assets
Total Stockholder Equity	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Good Will	+ 0.99	Total Stockholder Equity
Good Will	+ 0.99	Non Current Assets Total
Total Liab	+ 0.98	Total Assets

Short Term Investments	- 0.85	Common Stock Total Equity
Short Term Investments	- 0.82	Net Receivables
Non Current Liabilities Total	- 0.69	Short Term Investments
Short Term Investments	- 0.66	Property Plant And Equipment Net
Short Term Investments	- 0.63	Non Current Assets Total
Short Term Investments	- 0.61	Total Assets